Related Experiment Video
Updated: Jun 23, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Compartmentalized Polymeric Nanoparticles Deliver Vancomycin in a pH-Responsive Manner
Merve Seray Ural1, Mario Menéndez-Miranda1, Giuseppina Salzano1
1Institut de Sciences Moléculaires d'Orsay, CNRS UMR 8214, Université Paris-Sud, Université Paris-Saclay, 91405 Orsay, France.
Abstract:
Vancomycin (VCM) is a last resort antibiotic in the treatment of severe Gram-positive infections. However, its administration is limited by several drawbacks such as: strong pH-dependent charge, tendency to aggregate, low bioavailability, and poor cellular uptake. These drawbacks were circumvented by engineering pH-responsive nanoparticles (NPs) capable to incorporate high VCM payload and deliver it specifically at slightly acidic pH corresponding to infection sites. Taking advantage of peculiar physicochemical properties of VCM, here we show how to incorporate VCM efficiently in biodegradable NPs made of poly(lactic-co-glycolic acid) and polylactic acid (co)polymers. The NPs were prepared by a simple and reproducible method, establishing strong electrostatic interactions between VCM and the (co)polymers' end groups. VCM payloads reached up to 25 wt%. The drug loading mechanism was investigated by solid state nuclear magnetic resonance spectroscopy. The engineered NPs were characterized by a set of advanced physicochemical methods, which allowed examining their morphology, internal structures, and chemical composition on an individual NP basis. The compartmentalized structure of NPs was evidenced by cryogenic transmission electronic microscopy, whereas the chemical composition of the NPs' top layers and core was obtained by electron microscopies associated with energy-dispersive X-ray spectroscopy. Noteworthy, atomic force microscopy coupled to infrared spectroscopy allowed mapping the drug location and gave semiquantitative information about the loadings of individual NPs. In addition, the NPs were stable upon storage and did not release the incorporated drug at neutral pH. Interestingly, a slight acidification of the medium induced a rapid VCM release. The compartmentalized NPs could find potential applications for controlled VCM release at an infected site with local acidic pH.
Insights
Engineered nanoparticles effectively encapsulate high payloads of vancomycin (VCM), a crucial antibiotic. These pH-responsive nanoparticles release VCM specifically at infection sites, overcoming administration challenges.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Pharmaceutical Sciences
Background:
- Vancomycin (VCM) is vital for severe Gram-positive infections but faces limitations including poor bioavailability and cellular uptake.
- Existing VCM delivery methods are hindered by its pH-dependent charge and aggregation tendencies.
Purpose of the Study:
- To engineer pH-responsive nanoparticles (NPs) for efficient vancomycin (VCM) encapsulation and targeted delivery.
- To overcome VCM's limitations by developing a novel nanoparticle system for improved therapeutic outcomes.
Main Methods:
- Biodegradable nanoparticles composed of poly(lactic-co-glycolic acid) and polylactic acid were fabricated using electrostatic interactions.
- Advanced techniques including solid-state NMR, cryo-TEM, EDX, and AFM-IR were employed for comprehensive characterization.
- In vitro studies assessed VCM release profiles at varying pH conditions.
Main Results:
- Nanoparticles achieved high VCM payloads up to 25 wt% through efficient electrostatic drug loading.
- Characterization confirmed a compartmentalized NP structure and detailed chemical composition.
- VCM-loaded NPs demonstrated stability at neutral pH and triggered rapid drug release upon slight acidification.
Conclusions:
- Engineered, compartmentalized nanoparticles offer a promising strategy for controlled vancomycin delivery.
- This pH-responsive system can enhance VCM efficacy at infection sites characterized by local acidic pH.
- The developed NPs address key limitations of vancomycin administration, paving the way for improved treatment of resistant infections.
Related Concept Videos
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Classification
Modified-Release Drug Delivery Systems: Rate-Programmed I
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers

